{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T04:21:55Z","timestamp":1729916515404,"version":"3.28.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,25]]},"DOI":"10.7759\/cureus.72373","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T15:09:41Z","timestamp":1729868981000},"source":"Crossref","is-referenced-by-count":0,"title":["Nivolumab-Induced Immune Mediated Colitis Localized to the Distal Colon: Seven Years Into Therapy"],"prefix":"10.7759","author":[{"given":"Christian J","family":"Nassif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imad I","family":"Nassif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Todorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Nivolumab injection. (2023). Accessed. July 30, 2023: https:\/\/medlineplus.gov\/druginfo\/meds\/a614056.html."},{"key":"ref2","article-title":"Nivolumab","author":"Rendon A","year":"2024","unstructured":"Rendon A, Rayi A. Nivolumab. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-019-03268-4","article-title":"Nivolumab-induced immune-mediated colitis: An ulcerative colitis look-alike-report of new cases and review of the literature","volume":"34","author":"Ca\u00f1ete F","year":"2019","unstructured":"Ca\u00f1ete F, Ma\u00f1osa M, Lobat\u00f3n T, et al.. Nivolumab-induced immune-mediated colitis: An ulcerative colitis look-alike-report of new cases and review of the literature. Int J Colorectal Dis. 2019, 34:861-5. 10.1007\/s00384-019-03268-4","journal-title":"Int J Colorectal Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-018-0864-1","article-title":"The characteristics of nivolumab-induced colitis: An evaluation of three cases and a literature review","volume":"18","author":"Yamauchi R","year":"2018","unstructured":"Yamauchi R, Araki T, Mitsuyama K, et al.. The characteristics of nivolumab-induced colitis: An evaluation of three cases and a literature review. BMC Gastroenterol. 2018, 18:135. 10.1186\/s12876-018-0864-1","journal-title":"BMC Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22070","article-title":"Rare adverse events related to nivolumab, an immune checkpoint inhibitor: A case series","volume":"14","author":"Ganta N","year":"2022","unstructured":"Ganta N, Alnabwani D, Keating S, Patel V, Bommu VJ, Dawoud R, Cheriyath P. Rare adverse events related to nivolumab, an immune checkpoint inhibitor: A case series. Cureus. 2022, 14:e22070. 10.7759\/cureus.22070","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14414","article-title":"Ipilimumab and nivolumab-induced colitis in a patient with recurrent metastatic melanoma","volume":"13","author":"Moein HR","year":"2021","unstructured":"Moein HR, Rutledge B, Beydoun R, Ehrinpreis MN. Ipilimumab and nivolumab-induced colitis in a patient with recurrent metastatic melanoma. Cureus. 2021, 13:e14414. 10.7759\/cureus.14414","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.800879","article-title":"Immune checkpoint inhibitor-associated colitis: From mechanism to management","volume":"12","author":"Tang L","year":"2021","unstructured":"Tang L, Wang J, Lin N, Zhou Y, He W, Liu J, Ma X. Immune checkpoint inhibitor-associated colitis: From mechanism to management. Front Immunol. 2021, 12:800879. 10.3389\/fimmu.2021.800879","journal-title":"Front Immunol"},{"key":"ref8","unstructured":"Opdivo. (2022). Accessed. July 30, 2023: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/search\/opdivo\/?searchMode=Begins."},{"key":"ref9","unstructured":"Immune-mediated adverse reactions management guide. (2023). Accessed. July 30, 2023: https:\/\/www.opdivohcp.com\/assets\/commercial\/us\/opdivo-hcp-pan-tumor\/en\/pdf\/Immune_Mediated_Adverse_Management_Guide.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-020-03638-3","article-title":"Remission of ulcerative colitis flare-up induced by nivolumab","volume":"35","author":"Iwamoto M","year":"2020","unstructured":"Iwamoto M, Kato K, Moriyama M, Yamaguchi K, Takahashi S. Remission of ulcerative colitis flare-up induced by nivolumab. Int J Colorectal Dis. 2020, 35:1791-5. 10.1007\/s00384-020-03638-3","journal-title":"Int J Colorectal Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00672","article-title":"Safety of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel disease and microscopic colitis","volume":"16","author":"Grover S","year":"2020","unstructured":"Grover S, Ruan AB, Srivoleti P, et al.. Safety of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel disease and microscopic colitis. JCO Oncol Pract. 2020, 16:e933-42. 10.1200\/JOP.19.00672","journal-title":"JCO Oncol Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/222051-nivolumab-induced-immune-mediated-colitis-localized-to-the-distal-colon-seven-years-into-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T15:09:43Z","timestamp":1729868983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/222051-nivolumab-induced-immune-mediated-colitis-localized-to-the-distal-colon-seven-years-into-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.72373","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}